Michael Howell - Apr 22, 2024 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Officer
Signature
/s/ Michael Howell
Stock symbol
ZURA
Transactions as of
Apr 22, 2024
Transactions value $
$24,999
Form type
4
Date filed
4/24/2024, 06:54 PM
Previous filing
May 22, 2023
Next filing
Aug 8, 2024
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZURA Class A ordinary shares Purchase $25K +7.99K $3.13 7.99K Apr 22, 2024 By corporation F1, F2
holding ZURA Class A ordinary shares 114K Apr 22, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired in a private placement transaction pursuant to the terms of that certain Securities Purchase Agreement, dated as of April 18, 2024, between the Issuer and Mountaineer Biosciences, Inc. ("Mountaineer") at a purchase price of $3.13 per share.
F2 These shares are beneficially owned by Mountaineer. The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.